Bill has spent his career in high-growth, market-defining technology companies with a focus on SaaS commercialization, revenue operations and go-to-market strategy in Healthcare.  Currently, Bill is the Chief Commercial Officer of Bayesian Health, the leading Clinical AI platform whose machine learning / AI and workflow solutions predict patient risks early and enable rapid, clinical intervention. Prior to joining Bayesian, Bill was the Vice President & General Manager of Butterfly Network's International business, where he led the company's international strategy and execution. Before taking on International expansion, Bill led Butterfly’s USA commercial business where he launched the company’s enterprise product and built the B2B revenue operations. During his tenure, Butterfly went public on the NYSE (February 2021).Prior to joining Butterfly, Bill was the Vice President & Head of Sales, Marketing, and Business Development at Force Therapeutics, a digital health company focused on home-based recovery from Musculoskeletal injury. He joined pre-revenue and led the company's GTM operations through its growth capital round.His first role in healthcare was as an early leader on ZocDoc’s enterprise team. Bill began his career at Capital IQ, a FinTech SaaS company, where he held a variety of client-facing and business development roles.